By following key strategies, companies can reduce the risk and increase the benefits of outsourcing analytical development and testing
Amy St. Charles
Advertisement
Amy St. Charles is a senior scientist in QC/Stability/Compliance in the Analytical Research and Development of Pfizer Global Biologics
Articles by Amy St. Charles
Advertisement
Latest Updated Articles
Use of Contract Analytical Laboratories: A Pfizer Global Biologics PerspectivePublished: July 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
